Ko Okumura Selected Research

Ko Okumura Research Topics

Disease

60	Inflammation (Inflammations) 04/2024 - 05/2002
34	Hypersensitivity (Allergy) 11/2023 - 05/2002
29	Neoplasms (Cancer) 10/2023 - 01/2002
20	Asthma (Bronchial Asthma) 04/2024 - 08/2002
20	Atopic Dermatitis (Atopic Eczema) 02/2024 - 12/2002
13	Eosinophilia 01/2024 - 10/2003
13	Infections 03/2016 - 06/2003
11	Wounds and Injuries (Trauma) 02/2024 - 03/2003
10	Contact Dermatitis (Eczema, Contact) 11/2022 - 10/2003
10	Colitis 05/2016 - 02/2003
9	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 12/2002
9	Food Hypersensitivity (Food Allergy) 01/2023 - 06/2005
8	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2023 - 07/2002
8	Anaphylaxis (Anaphylactic Shock) 01/2023 - 05/2002
8	type 2C Congenital disorder of glycosylation 01/2022 - 04/2010
7	Virus Diseases (Viral Diseases) 10/2023 - 01/2009
6	Neoplasm Metastasis (Metastasis) 03/2021 - 09/2003
6	Necrosis 06/2012 - 01/2002
5	Dermatitis 05/2023 - 12/2015
5	Reperfusion Injury 01/2021 - 12/2005
5	Arthritis (Polyarthritis) 01/2019 - 10/2002
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2011 - 08/2002
5	Rheumatoid Arthritis 03/2010 - 10/2002
5	Skin Diseases (Skin Disease) 01/2009 - 12/2002
4	Respiratory Hypersensitivity 04/2024 - 12/2002
4	Disease Progression 03/2024 - 08/2002
4	Hypoxia (Hypoxemia) 03/2024 - 09/2015
4	Fibrosis (Cirrhosis) 10/2023 - 08/2004
4	Hyperplasia 03/2017 - 02/2007
4	Experimental Arthritis 03/2011 - 10/2002
3	Allergic Rhinitis 04/2024 - 09/2010
3	Seasonal Allergic Rhinitis (Hay Fever) 11/2023 - 03/2008
3	Ischemia 01/2021 - 05/2010
3	Ischemic Stroke 01/2019 - 07/2009
3	Leukemia 01/2018 - 05/2002
3	Pneumonia (Pneumonitis) 12/2017 - 09/2012
3	Sepsis (Septicemia) 01/2017 - 05/2002
3	Fibrosarcoma 01/2017 - 10/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 06/2002
3	Hepatitis 12/2012 - 01/2009
3	Myocarditis (Carditis) 07/2007 - 04/2002

Drug/Important Bio-Agent (IBA)

44	CytokinesIBA 04/2024 - 05/2002
37	Immunoglobulin E (IgE)IBA 04/2024 - 05/2002
30	AllergensIBA 11/2023 - 04/2003
23	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2002
22	AntigensIBA 01/2024 - 05/2002
20	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2002
20	LigandsIBA 12/2015 - 01/2002
19	Monoclonal AntibodiesIBA 03/2024 - 01/2002
17	Interleukin-33IBA 05/2023 - 12/2009
16	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 01/2002
11	ChemokinesIBA 01/2022 - 12/2002
10	Thymic Stromal LymphopoietinIBA 01/2021 - 05/2007
10	OvalbuminIBA 01/2021 - 04/2003
10	Transforming Growth Factor beta (TGF-beta)IBA 09/2010 - 08/2002
9	Immunoglobulin G (IgG)IBA 03/2024 - 10/2002
9	TNF-Related Apoptosis-Inducing LigandIBA 01/2020 - 10/2002
8	PapainIBA 01/2024 - 05/2013
8	AntibodiesIBA 01/2021 - 05/2002
7	IgE Receptors (Fc epsilon RI)IBA 12/2020 - 07/2002
6	Messenger RNA (mRNA)IBA 11/2022 - 10/2003
6	Peptides (Polypeptides)IBA 01/2022 - 06/2005
6	Therapeutic UsesIBA 01/2022 - 09/2003
6	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2020 - 02/2004
6	Dermatophagoides pteronyssinus antigen p 1IBA 12/2011 - 07/2005
5	Apoptosis Regulatory ProteinsIBA 03/2024 - 11/2016
5	VaccinesIBA 01/2023 - 03/2009
5	MucinsIBA 01/2023 - 02/2007
5	Interleukin-4 (Interleukin 4)IBA 01/2022 - 10/2003
5	Interleukin-13IBA 12/2020 - 10/2003
4	CeramidesIBA 04/2024 - 05/2016
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 10/2012
4	Interleukin-1 (Interleukin 1)IBA 11/2019 - 10/2010
4	HaptensIBA 11/2018 - 10/2003
4	Dextrans (Dextran)FDA Link 05/2016 - 08/2010
4	Interleukin-10 (Interleukin 10)IBA 07/2013 - 10/2003
4	Dermatophagoides farinae antigen f 1IBA 05/2013 - 07/2005
4	Neutralizing AntibodiesIBA 12/2012 - 06/2005
4	Thromboplastin (Tissue Factor)IBA 02/2011 - 07/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2009 - 01/2003
3	Conditioned Culture MediaIBA 03/2024 - 09/2015
3	Tyrosine (L-Tyrosine)FDA Link 03/2024 - 09/2015
3	Antimicrobial PeptidesIBA 03/2023 - 04/2016
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2021 - 01/2016
3	EnzymesIBA 02/2021 - 01/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020 - 05/2002
3	Interleukin-2 (IL2)IBA 01/2020 - 10/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 08/2002
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2016 - 08/2010
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2015 - 10/2012
3	CollagenIBA 11/2013 - 12/2005
3	Fas Ligand Protein (Fas Ligand)IBA 12/2012 - 01/2005
3	InterferonsIBA 12/2012 - 01/2002
3	Phosphotransferases (Kinase)IBA 08/2011 - 02/2007
3	Collagen Type II (Type II Collagen)IBA 05/2007 - 10/2002

Therapy/Procedure

15	Therapeutics 04/2024 - 08/2002
14	Immunotherapy 01/2021 - 04/2002
4	Ligation 01/2023 - 04/2005
3	Transplantation 04/2024 - 09/2003
3	Oral Administration 01/2008 - 06/2005